Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mariela Alejandra Moreno Ayala"'
Autor:
Antonela Sofía Asad, Camila Florencia Zuccato, Alejandro Javier Nicola Candia, María Florencia Gottardo, Mariela Alejandra Moreno Ayala, María Susana Theas, Adriana Seilicovich, Marianela Candolfi
Publikováno v:
NOVA, Vol 17, Iss 32, Pp 9-24 (2019)
La humanina es un péptido derivado de la mitocondria con efectos protectores robustos contra una gran variedad de estímulos citotóxicos en diversos tipos celulares. Esto la convierte en un blanco terapéutico interesante para muchas enfermedades,
Externí odkaz:
https://doaj.org/article/27e6c1b9c8c1435488e00d7fc208aaa6
Autor:
Alejandro Javier Nicola-Candia, Adriana Seilicovich, María Florencia Gottardo, Mariela Alejandra Moreno-Ayala, Camila Florencia Zuccato, Marianela Candolfi, Antonela Sofía Asad, María Susana Theas
Publikováno v:
NOVA, Vol 17, Iss 32, Pp 9-24 (2019)
Nova, Volume: 17, Issue: 32, Pages: 24-9, Published: DEC 2019
Nova, Volume: 17, Issue: 32, Pages: 24-9, Published: DEC 2019
Resumen La humanina es un péptido derivado de la mitocondria con efectos protectores robustos contra una gran variedad de estímulos citotóxicos en diversos tipos celulares. Esto la convierte en un blanco terapéutico interesante para muchas enferm
Autor:
María Susana Theas, Alejandro Javier Nicola Candia, Mariela Alejandra Moreno Ayala, Adriana Seilicovich, María Florencia Gottardo, Camila Florencia Zuccato, Marianela Candolfi, Antonela Sofía Asad
Introduction: Mitochondrial-derived peptides (MDPs) are encoded within the mitochondrial genome. They signal within the cell or are released to act as autocrine/paracrine/endocrine cytoprotective factors playing a key role in the cellular stress resp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88dc20d56f88460b24d538cb2b1cb8d4
https://www.tandfonline.com/doi/abs/10.1080/14728222.2019.1559300?journalCode=iett20
https://www.tandfonline.com/doi/abs/10.1080/14728222.2019.1559300?journalCode=iett20
Publikováno v:
Immunology
Overcoming the immunosuppressive tumour microenvironment is the major challenge impeding cancer immunotherapy today. Regulatory T-cells (Tregs) are prevalent in nearly all cancers and, as immunosuppressive regulators of immune responses, they are the